Company Filing History:
Years Active: 2014
Title: Marta Adeva Bartolome: Innovator in Pharmaceutical Research
Introduction
Marta Adeva Bartolome is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceutical research, particularly in the development of selective receptor agonists. Her work focuses on addressing various mental health disorders and obesity through innovative chemical compounds.
Latest Patents
Marta holds a patent for a groundbreaking invention that provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I). This invention serves as selective 5-HT2c receptor agonists for the treatment of 5-HT2c associated disorders, including obesity, obsessive-compulsive disorder, depression, and anxiety. The specific structure of the compound includes R6 as —NR10R11, where R10 is substituted phenylalkyl or substituted pyridylalkyl, along with other defined substituents.
Career Highlights
Marta is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves extensive research and development, contributing to the advancement of therapeutic solutions for various health conditions.
Collaborations
Marta has collaborated with notable colleagues, including Karen Briner and Manuel Javier Cases-Thomas. These partnerships have enhanced her research efforts and fostered innovation within her projects.
Conclusion
Marta Adeva Bartolome is a distinguished inventor whose work in pharmaceutical research is paving the way for new treatments for mental health disorders and obesity. Her innovative contributions continue to impact the field positively.